Loading
German GI oncologist who leads ESMO's gastric cancer guidelines and pivotal perioperative trials.
Florian Lordick (University Cancer Center Leipzig) led the MUNICON trials of PET-guided treatment and is a principal investigator on trials of perioperative immunotherapy and HER2-directed therapy in gastro-oesophageal cancer. He chairs the ESMO gastric cancer guideline group and has served on the ESMO executive board. His work focuses on tailoring perioperative therapy and on nutrition in GI cancer.
| Title | Journal | Year |
|---|---|---|
| Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up | Annals of Oncology | 2022 |
| PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial | Lancet Oncology | 2007 |
Shares Annals of Oncology, Gastric & gastro-oesophageal junction cancer and the tags guidelines, esmo.
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag guidelines.
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag guidelines.
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.